Working… Menu

Embryo Kinetics and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01678651
Recruitment Status : Terminated
First Posted : September 5, 2012
Last Update Posted : February 24, 2016
Information provided by (Responsible Party):
IVI Madrid

Brief Summary:
Different kinetics markers have been proposed to select embryos with higher implantation rates. The effect of external factors on these markers, such as the stimulation protocol should be analyzed. There are two different types of FSH that are commonly used for in vitro fertilization (IVF) in egg donation cycles, recombinant FSH and human FSH. The effect of each kind of hormone on embryo kinetcis is still unknown. The aim of this study is to observe if there is a difference in embryo kinetics and morphology as well as oocyte morphological parameters between the two types of FSH and therefore to analyze if such markers can be used despite of the stimulation protocols chosen.

Condition or disease Intervention/treatment Phase
Embryo Kinetics Procedure: Stimulation with human FSH Procedure: Stimulation with recombinant FSH Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Embryo Kinetcis From Embryos Deriving From Egg Donation Cycle With Different Stimulation Protocol: Recombinant FSH vs Human FSH
Study Start Date : August 2012
Actual Primary Completion Date : February 2013
Actual Study Completion Date : February 2013

Arm Intervention/treatment
Active Comparator: Human FSH
Human FSH
Procedure: Stimulation with human FSH
Human FSH

Active Comparator: Recombinant FSH
Recombinant FSH
Procedure: Stimulation with recombinant FSH
Recombinant FSH

Primary Outcome Measures :
  1. time of cell cleavage [ Time Frame: February 2012 ]
    Analysis of cell cleavage

Secondary Outcome Measures :
  1. Embryo and oocyte morphology [ Time Frame: February 2012 ]
    Analysis of all oocytes

  2. Outcome rates (implantation, pregnancy and miscarriage rate) [ Time Frame: February 2012 ]
    Time requierd to know all the implantation, pregnancy and miscarriage rate

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

•Egg donation cycles with more than 8MII in oocyte retrieval day

Exclusion Criteria:

  • Male factor
  • Uterine malformations
  • genetic alterations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01678651

Layout table for location information
Insituto Valenciano de Infertilida
Madrid, Spain, 28023
Sponsors and Collaborators
IVI Madrid
Layout table for additonal information
Responsible Party: IVI Madrid Identifier: NCT01678651    
Other Study ID Numbers: MAD-NB-08-2012-01
First Posted: September 5, 2012    Key Record Dates
Last Update Posted: February 24, 2016
Last Verified: March 2015
Keywords provided by IVI Madrid:
time-lapse, FSH, kinetics